A PHASE 3B, OPEN LABEL, CONTROLLED, MULTI CENTER, EXTENSION STUDY TO ASSESS THE PERSISTENCE OF BACTERICIDAL ACTIVITY AT 4 TO 7.5 YEARS AFTER TWO DOSE PRIMARY SERIES OF NOVARTIS MENINGOCOCCAL B RECOMBINANT VACCINE AND THE RESPONSE TO A THIRD DOSE IN ADOLESCENTS AND YOUNG ADULT SUBJECTS WHO PREVIOUSLY PARTICIPATED IN PARENT STUDIES V72_41 AND V72PI0, COMPARED TO NAIVE HEALTHY CONTROLS
- Registry ID
- V72_75
- Source registry
- HEALTH_CANADA
- Status
- Ongoing
- Phase
- PHASE3
- Study type
- INTERVENTIONAL
- Sponsor
- NOVARTIS VACCINES AND DIAGNOSTICS INC
- Start date
- 2015-11-05
- Last update
- 2015-09-17
Conditions
- MENINGITIS B
- IMMUNIZATION
Related clinical trials
- A PHASE III, RANDOMIZED, CONTROLLED, OBSERVER-BLIND STUDY TO DOMONSTRATE EFFECTIVENESS, IMMUNOGENICITY AND SAFETY OF GSK'S MENINGOCOCCAL GROUP B AND COMBINED ABCWY VACCINES WHEN ADMINISTERED TO HEALTHY ADOLESCENTS AND YOUNG ADULTS
- A PHASE 3 DOUBLE-BLIND RANDOMIZED CONTROLLED TRIAL TO COMPARE THE IMMUNOGENICITY AND SAFETY OF A THREE-DOSE REGIMEN OF SCI-B-VAC TO A THREE-DOSE REGIMEN OF ENGERIX-B IN ADULTS
- A DOUBLE-BLIND RANDOMIZED CONTROLLED TRIAL TO ASSESS THE LOT-TO-LOT CONSISTENCY OF SCI-B-VAC IN ADULTS
- A PHASE 3, PLACEBO-CONTROLLED, RANDOMIZED, OBSERVER-BLINDED STUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF A CLOSTRIDIUM DIFFICILE VACCINE IN ADULTS 50 YEARS OF AGE AND OLDER
- VACCINATING CHILDREN AFTER CHEMOTHERAPY FOR ACUTE LYMPHOBLASTIC LEUKEMIA
- A PHASE IV, OPEN-LABEL, NON-RANDOMISED, MULTICENTRE STUDY TO ASSESS THE LONG-TERM PERSISTENCE OF IMMUNITY TO HEPATITIS B IN ADULTS VACCINATED 20 TO 30 YEARS AGO WITH 3 OR 4 DOSES OF GSK BIOLOGICALS' HEPATITIS B VACCINE, ENGERIX-B
View on source registry